Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$463.22K$463.22Kderived+5.4% vs Q4 2012 Net Income-$1.49M-$1.49MderivedN/M vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$353,970+118.2% Operating Cash Flowderived-$636,856N/M Free Cash Flowderived-$666,748— Margins · derivedGross margin76.4%+39.5 pt vs Q4 2012
Net margin-320.8%−160.3 pt vs Q4 2012
ended Dec 31, 2013 · filed Apr 14, 2014 · 104 d after period end